By Chris Hutching
|
Friday 22nd November 2002 |
Text too small? |
Brokers said investors keen on the stock had already bought shares in recent months when the price reached a high of 20c. Listed Southern Capital, another in Mr Paterson's stable, owns 4.3% of the 166,666,666 shares on issue bought at 10c a share.
Botry-Zen manufactures a biological control against fruit fungus Botrytis cinerea, which often affects grapevines. The company forecasts sales of $1.2 million next year and a $135,000 profit in the year to March 31, 2004, but expects a $926,000 shortfall this year as it sets up operations.
Botry-Zen was initially floated last year to private investors in a $5 million capital raising. In July it was granted registration for grape application under the Pesticides Act.
No comments yet
June 2nd Morning Report
IKE - FY26 Financial Results
Chorus submits 2025 fibre regulatory report
SPG - FY26 Annual Results
PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026